ANIMALCARE GROUP PLC
(the "Company" or the "Group")
Notice of Results and Presentations
16 April 2025 - Animalcare Group plc (AIM: ANCR), the international animal health business, will announce its results for the year ended 31 December 2024 on Tuesday, 29 April 2025.
The Company will host an analyst presentation at 10.00am on the day of results and an investor presentation at 12.00pm on Tuesday, 6 May 2025. Both presentations will be hosted by Jenny Winter, CEO, and Chris Brewster, CFO.
Virtual analyst presentation - 10.00am on Tuesday, 29 April 2025
Should you wish to attend, please email animalcare@almastrategic.com
Virtual investor presentation - 12.00pm on Tuesday, 6 May 2025
Should you wish to attend, please register via the Investor Meet Company platform using the following link:
https://www.investormeetcompany.com/animalcare-group-plc/register-investor
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven European countries as well as Australia and New Zealand and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com or contact:
|
Animalcare Group Plc |
+44 (0)1904 487 687 |
|
Jenny Winter, Chief Executive Officer |
|
|
Chris Brewster, Chief Financial Officer |
|
|
Media/investor relations |
|
|
|
|
|
Stifel Nicolaus Europe Limited (Nominated Advisor & Joint Broker) |
+44 (0)20 7710 7600 |
|
Ben Maddison |
|
|
Nicholas Harland |
|
|
Francis North |
|
|
|
|
|
Panmure Liberum (Joint Broker) |
+44 (0)20 7886 2500 |
|
Corporate Finance Freddy Crossley/Emma Earl |
|
|
Corporate Banking Rupert Dearden |
|
|
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Caroline Forde |
|
|
Andy Bryant |
|
|
Kinvara Verdon |
|
|
Rose Docherty |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
